04:45 PM EST, 02/07/2025 (MT Newswires) -- Behrad Derakhshan, Chief Business Officer, on February 05, 2025, sold 10,000 shares in Edgewise Therapeutics ( EWTX ) for $300,300. Following the Form 4 filing with the SEC, Derakhshan has control over a total of 16,837 common shares of the company, with 16,837 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1710072/000156218025001024/xslF345X05/primarydocument.xml